Adjanie Patabendige

Has grant

Associate Professor of Biomedical Science

University of Derby

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adjanie Patabendige is an Associate Professor of Biomedical Science at the University of Derby, UK. Her research areas focus on cerebrospinal fluid dynamics, blood-brain barrier disruption, and preclinical treatments for diffuse midline glioma. She has contributed to several recent articles exploring the implications of cerebrospinal fluid clearance in neurological diseases and innovative therapeutic strategies for brain conditions.

Recent Grants

Grant: Close

Vector competence of British mosquitoes to flaviviruses

Open Date: 2013-11-25

Close Date: 2017-11-24

Grant: Close

Optimisation of a flow-based human in vitro blood-brain barrier model

Open Date: 2012-08-31

Close Date: 2016-03-30

Articles (10)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (5)

Mika L. Persson

Newcastle University

AUSTRALIA

View details

Raelene Endersby

University of Western Australia

AUSTRALIA

View details

Zacary Germon

University of Newcastle Australia

AUSTRALIA

View details

Kirsten Coupland

Karolinska Institutet

SWEDEN

View details

Samuel MEIGNAN

Head of Laboratory

Centre Oscar Lambret

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adjanie Patabendige

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

Altered cerebrospinal fluid clearance and increased intracranial pressure in rats 18 h after experimental cortical ischaemia

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

Blood-brain barrier disruption in dementia: Nano-solutions as new treatment options.

EXTH-36. COMBINING ONC201 AND PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA (DMG); THE PRECLINICAL RESULTS UNDERPINNING THE INTERNATIONAL PHASE II CLINICAL TRIAL (NCT05009992)

The role of the blood-brain barrier during neurological disease and infection

Editorial: Cerebrospinal fluid dynamics and intracranial pressure elevation–Novel insights on molecular and physiological mechanisms, and implications for neurological disease

Astrocytic aquaporin 4 subcellular translocation as a therapeutic target for cytotoxic edema in ischemic stroke.

An Improved In Vitro Porcine Blood-Brain Barrier Model for Permeability Screening and Functional Studies.

Short-duration hypothermia completed prior to reperfusion prevents intracranial pressure elevation following ischaemic stroke in rats.

Collaborators (5)

Mika L. Persson

Raelene Endersby

Zacary Germon

Kirsten Coupland

Samuel MEIGNAN

Make your next move.